Inactive Instrument

Skyline Medical Inc Stock Nasdaq

Equities

US83084T3095

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq
- USD - Intraday chart for Skyline Medical Inc
Sales 2022 1.51M Sales 2023 1.78M Capitalization 13.37M
Net income 2022 -25M Net income 2023 -14M EV / Sales 2022 1.5 x
Net cash position 2022 21.89M Net cash position 2023 5.87M EV / Sales 2023 4.21 x
P/E ratio 2022
-0.87 x
P/E ratio 2023
-0.94 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.45%
More Fundamentals * Assessed data
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.
More about the company